Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02398240 |
| Title | Brentuximab for Newly Diagnosed Hodgkin Disease |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Mitchell Cairo |
| Indications | |
| Therapies | |
| Age Groups: | child | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| New York Medical College | Valhalla | New York | 10595 | United States | Details |